Novel imaging techniques as response biomarkers in cervical cancer (Q37683110)

22 August 2017

1 reference

title

Novel imaging techniques as response biomarkers in cervical cancer (English)

1 reference

22 August 2017

0 references

cervix uterine cancer

1 reference

Vanessa N Harry

1

1 reference

PubMed ID

20109726

22 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

116

1 reference

22 August 2017

2

1 reference

22 August 2017

253-261

1 reference

Dynamic contrast-enhanced magnetic resonance imaging in oncology.

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Pathophysiologic basis of contrast enhancement in breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic contrast-enhanced magnetic resonance imaging in radiotherapeutic efficacy in the head and neck tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Assessment of Irradiated Brain Metastases by Means of Arterial Spin-Labeling and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumour regression rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

[Angiogenesis of cervix carcinoma. Contrast enhanced dynamic MRI, histologic quantification of capillary density and lymphatic system infiltration]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted MRI: a new functional clinical technique for tumour imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Apparent diffusion coefficient (ADC) measurements may be more reliable and reproducible than lesion volume on diffusion-weighted images from patients with acute ischaemic stroke-implications for study design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

ADC mapping of benign and malignant breast tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery--preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted MRI in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

In vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo1H MR Spectroscopy—A Pilot Study at 4 T

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

(1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Lymph node staging by positron emission tomography in patients with carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

The prognostic value of pretreatment 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography scan in women with cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Where are we with imaging oxygenation in human tumours?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.003

10.1016/J.YGYNO.2009.11.003

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20109726